PH12021551725A1 - Complex of gadolinium and a chelating ligand derived from a diastereoisomerically enriched pcta and preparation and purification process - Google Patents

Complex of gadolinium and a chelating ligand derived from a diastereoisomerically enriched pcta and preparation and purification process

Info

Publication number
PH12021551725A1
PH12021551725A1 PH1/2021/551725A PH12021551725A PH12021551725A1 PH 12021551725 A1 PH12021551725 A1 PH 12021551725A1 PH 12021551725 A PH12021551725 A PH 12021551725A PH 12021551725 A1 PH12021551725 A1 PH 12021551725A1
Authority
PH
Philippines
Prior art keywords
complex
pcta
gadolinium
preparation
purification process
Prior art date
Application number
PH1/2021/551725A
Other languages
English (en)
Inventor
Martine Cerf
Alain Chã‰Nedã‰
Bruno Franã‡Ois
Greneur Soizic Le
Stã©Phanie Louguet
Emmanuelle Marais
Myriam Petta
Caroline Robic
Original Assignee
Guerbet Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guerbet Sa filed Critical Guerbet Sa
Publication of PH12021551725A1 publication Critical patent/PH12021551725A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PH1/2021/551725A 2019-01-17 2020-01-17 Complex of gadolinium and a chelating ligand derived from a diastereoisomerically enriched pcta and preparation and purification process PH12021551725A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1900432A FR3091873B1 (fr) 2019-01-17 2019-01-17 Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification
PCT/EP2020/051153 WO2020148436A1 (fr) 2019-01-17 2020-01-17 Complexe de gadolinium et d'un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification

Publications (1)

Publication Number Publication Date
PH12021551725A1 true PH12021551725A1 (en) 2022-04-11

Family

ID=67001953

Family Applications (1)

Application Number Title Priority Date Filing Date
PH1/2021/551725A PH12021551725A1 (en) 2019-01-17 2020-01-17 Complex of gadolinium and a chelating ligand derived from a diastereoisomerically enriched pcta and preparation and purification process

Country Status (28)

Country Link
US (3) US11590246B2 (https=)
EP (2) EP3902800B1 (https=)
JP (2) JP7071596B2 (https=)
KR (2) KR102438394B1 (https=)
CN (3) CN113646308B (https=)
AR (1) AR117835A1 (https=)
AU (1) AU2020208794B2 (https=)
BR (1) BR112021014006B1 (https=)
CA (1) CA3126268C (https=)
CL (1) CL2021001868A1 (https=)
CO (1) CO2021009261A2 (https=)
DK (2) DK3943493T3 (https=)
ES (2) ES2930136T3 (https=)
FI (1) FI3943493T3 (https=)
FR (1) FR3091873B1 (https=)
HR (2) HRP20230678T1 (https=)
HU (2) HUE062554T2 (https=)
IL (1) IL284884B2 (https=)
MA (2) MA54626A (https=)
MX (1) MX2021008651A (https=)
PH (1) PH12021551725A1 (https=)
PL (2) PL3943493T3 (https=)
PT (2) PT3943493T (https=)
RS (1) RS64334B1 (https=)
SG (1) SG11202107779SA (https=)
TW (1) TWI811518B (https=)
WO (1) WO2020148436A1 (https=)
ZA (1) ZA202104994B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT4151637T (pt) 2018-08-06 2025-03-26 Bracco Imaging Spa Agentes de contraste à base de pcta que suportam gadolínio
FR3091873B1 (fr) * 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification
FR3091872B1 (fr) * 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de synthese
KR20230041007A (ko) * 2020-07-17 2023-03-23 게르브 Pcta로부터 유도된 킬레이팅 리간드의 제조 방법
KR20230074593A (ko) * 2020-10-02 2023-05-30 이글 하버 테크놀로지스, 인코포레이티드 이온 전류 드룹 보상
WO2024049087A1 (ko) * 2022-09-01 2024-03-07 주식회사 테라노큐어 신규한 화합물 및 이를 포함하는 mri 조영제
KR102845061B1 (ko) * 2022-09-01 2025-08-13 주식회사 테라노큐어 신규한 화합물 및 이를 포함하는 mri 조영제
WO2026027591A1 (en) 2024-07-31 2026-02-05 Bracco Imaging Spa Synthesis of an intermediate of a gadolinium-based contrast agent

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647447A (en) 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
DE3640708C2 (de) 1986-11-28 1995-05-18 Schering Ag Verbesserte metallhaltige Pharmazeutika
DE4001655A1 (de) 1990-01-18 1991-07-25 Schering Ag 6-ring enthaltende makrocyclische tetraaza-verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
JPH04154729A (ja) 1990-10-16 1992-05-27 Nippon Mejifuijitsukusu Kk 磁気共鳴造影剤
IT1292128B1 (it) 1997-06-11 1999-01-25 Bracco Spa Processo per la preparazione di chelanti macrociclici e loro chelati con ioni metallici paramagnetici
EP0992245A1 (en) 1998-09-16 2000-04-12 Goldham Bioglan Pharma GmbH Radio-contrast agents
FR2793795B1 (fr) * 1999-05-21 2001-08-03 Guerbet Sa Isomeres de tetramides du complexe de gadolinium de l'acide (1,4,7,10-tetrazacyclododecane)1,4,7,10-tetra(2-glutarique) leur procede de preparation et leur application en imagerie medicale
FR2794744B1 (fr) 1999-06-09 2001-09-21 Guerbet Sa Complexes metalliques de polyaminoacides bicycliques, leur procede de preparation et leur application en imagerie medicale
FR2891830B1 (fr) 2005-10-07 2011-06-24 Guerbet Sa Composes a chaines aminoalcools courtes et complexes metalliques pour l'imagerie medicale
US20090208421A1 (en) * 2008-02-19 2009-08-20 Dominique Meyer Process for preparing a pharmaceutical formulation of contrast agents
US8119817B2 (en) * 2009-09-29 2012-02-21 Degussa-Huels Ag Process for separating the diastereomers of RSS-and SSS-N- α [1-carboxy-3-phenylpropyl] lysylproline
EP2786768A1 (en) 2013-04-04 2014-10-08 Agfa Healthcare Process for preparing a material comprising a macrocyclic ligand and for producing a pharmaceutical formulation comprising said ligand with a lanthanide
CN105142649A (zh) * 2013-04-26 2015-12-09 法国加柏公司 造影剂配制品与有关制备方法
CN104188957B (zh) * 2014-05-28 2017-04-26 中国中医科学院西苑医院 一种防治再狭窄的药物及其制备和使用方法
WO2018199040A1 (ja) * 2017-04-28 2018-11-01 株式会社大塚製薬工場 クエン酸誘導体のジアステレオマーの製造方法
PT4151637T (pt) * 2018-08-06 2025-03-26 Bracco Imaging Spa Agentes de contraste à base de pcta que suportam gadolínio
FR3091873B1 (fr) * 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification
FR3091872B1 (fr) * 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de synthese

Also Published As

Publication number Publication date
AU2020208794A1 (en) 2021-08-05
US20230149568A1 (en) 2023-05-18
KR102502862B1 (ko) 2023-02-23
WO2020148436A1 (fr) 2020-07-23
TWI811518B (zh) 2023-08-11
PT3943493T (pt) 2023-07-12
HUE060343T2 (hu) 2023-02-28
HRP20230678T1 (hr) 2023-09-29
CN113735854B (zh) 2024-05-14
FI3943493T3 (fi) 2023-07-19
CN113646308B (zh) 2024-12-13
MA55389A (fr) 2022-01-26
FR3091873B1 (fr) 2020-12-25
IL284884B2 (en) 2025-09-01
US12064487B2 (en) 2024-08-20
BR112021014006A2 (pt) 2021-09-21
CN113735854A (zh) 2021-12-03
EP3902800A1 (fr) 2021-11-03
CL2021001868A1 (es) 2022-01-21
HRP20221402T1 (hr) 2023-01-06
JP2022508496A (ja) 2022-01-19
KR102438394B1 (ko) 2022-09-01
ES2930136T3 (es) 2022-12-07
CO2021009261A2 (es) 2021-12-10
AR117835A1 (es) 2021-08-25
CA3126268A1 (fr) 2020-07-23
KR20210138134A (ko) 2021-11-18
US20240358863A1 (en) 2024-10-31
DK3943493T3 (da) 2023-07-24
ES2950118T3 (es) 2023-10-05
JP2022009463A (ja) 2022-01-14
TW202043227A (zh) 2020-12-01
PL3902800T3 (pl) 2022-12-27
EP3943493A1 (fr) 2022-01-26
JP7071596B2 (ja) 2022-05-19
JP7321230B2 (ja) 2023-08-04
MA54626A (fr) 2022-04-20
SG11202107779SA (en) 2021-08-30
PL3943493T3 (pl) 2023-08-07
RS64334B1 (sr) 2023-08-31
CN119552163A (zh) 2025-03-04
MX2021008651A (es) 2021-10-26
PT3902800T (pt) 2022-11-16
US20220062443A1 (en) 2022-03-03
FR3091873A1 (fr) 2020-07-24
AU2020208794B2 (en) 2023-01-12
EP3943493B1 (fr) 2023-04-19
IL284884A (en) 2021-08-31
DK3902800T3 (da) 2022-11-28
KR20210109039A (ko) 2021-09-03
CN113646308A (zh) 2021-11-12
ZA202104994B (en) 2023-04-26
BR112021014006B1 (pt) 2023-05-02
EP3902800B1 (fr) 2022-09-07
IL284884B1 (en) 2025-05-01
HUE062554T2 (hu) 2023-11-28
CA3126268C (fr) 2024-01-09
US11590246B2 (en) 2023-02-28

Similar Documents

Publication Publication Date Title
PH12021551725A1 (en) Complex of gadolinium and a chelating ligand derived from a diastereoisomerically enriched pcta and preparation and purification process
MX2026001321A (es) Complejo de gadolinio y un ligando quelatante derivado de pcta diastereoisomericamente enriquecido y metodo de sintesis
MX2025003876A (es) Compuestos para el tratamiento de enfermedades mediadas por alfa-1 antitripsina
TW200519075A (en) Novel compounds
IL72120A0 (en) 2-pyrimidinyl-1-piperazine derivatives,their preparation and pharmaceutical compositions containing them
PL1797105T3 (pl) Zawierające fosfor pochodne heptazyny, sposób ich wytwarzania i ich zastosowanie jako środków ogniochronnych
UA86614C2 (ru) Соединение, которое имеет активность ингибитора киназ, фармацевтическая композиция, которая включает указанное соединение, и их применение для приготовления лекарственного препарата
DE3174844D1 (en) Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them
NO20073257L (no) 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same
MY209603A (en) Hydroxypyridoxazepines as nrf2 activators
MX2024001417A (es) Compuestos de heteroarilo para tratar la enfermedad de huntington.
ZA202107777B (en) Voruciclib polymorphs and methods of making and using thereof
MX2021005343A (es) Proceso para la preparacion de isoxazolinas opticamente enriquecidas.
JOP20250086A1 (ar) عملية لتحضير عامل تباين من الجادولينيوم
MXPA04002282A (es) Nuevos compuestos y preparaciones como inhibidores de la catepsina.
PH12022552553A1 (en) Substituted 3-phenoxyazetidin-1-yl-pyrazines having gpr52 agonistic activity
IL165220A0 (en) Novel compounds, their use and preparation
MX2023010998A (es) Un compuesto de quinolona en formas solidas y procesos para su preparacion.
MX2025006291A (es) Metodos de tratamiento de trastornos neurologicos
MX2023005273A (es) Composiciones farmaceuticas de un inhibidor de cinasa.
ES8103112A1 (es) Procedimiento para la obtencion de pseudo-trisacaridos
MX2021000226A (es) Nuevo proceso para la preparacion de diamidas antranilicas.
MY207529A (en) Use of pediococcus acidilactici gka4 in preparation of composition for preventing or treating renal dysfunction
MX2023007382A (es) Composiciones y métodos relacionados con compuestos que contienen biciclo [2.2.1] heptanamina di-sustituida.
ES438736A1 (es) Procedimiento para preparar esteres del acido dihidro-16, 17 apovincaminico.